Zdrowie i gospodarka · 04/11/2022

FDA Reclassifies HIV Viral Load Monitoring Tests from Class III to Class II Devices

The US Food and Drug Administration is reclassifying human immunodeficiency virus viral load monitoring tests from Class III to Class II devices, reducing regulatory burdens for manufacturers and allowing them to submit a less burdensome premarket notification instead of a premarket approval application.